Related references
Note: Only part of the references are listed.R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
Susan C. Williams et al.
ACTA NEUROPATHOLOGICA (2011)
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
Nanne K. Kloosterhof et al.
LANCET ONCOLOGY (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2010)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Philippe Metellus et al.
ACTA NEUROPATHOLOGICA (2010)
Glioma-derived mutations in IDH: From mechanism to potential therapy
Yuejun Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip
Christian Frezza et al.
CANCER CELL (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J. van den Bent et al.
CLINICAL CANCER RESEARCH (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
Zachary J. Reitman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model
Ken Matsumoto et al.
CANCER SCIENCE (2009)
IDH1 Mutations at Residue p.R132 (IDH1R132) Occur Frequently in High-Grade Gliomas But Not in Other Solid Tumors
Fonnet E. Bleeker et al.
HUMAN MUTATION (2009)
Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum
Susanne Schlisio
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, ion gliomas
Tatsuya Kobayashi et al.
CLINICAL CANCER RESEARCH (2007)
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer
Hajime Nakamura et al.
SEMINARS IN CANCER BIOLOGY (2006)
A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion
Sarah M. Ronnebaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies
C Bouvier et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Prediction of pathology and survival by FDG PET in gliomas
MV Padma et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
FDG-PET as a prognostic factor in high-grade astrocytoma
O De Witte et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
